- Q1 2024 Travere Therapeutics Inc Earnings Call TranscriptMay 06, 2024$6.55 (+4.63%)Earnings
- Q4 2023 Travere Therapeutics Inc Earnings Call TranscriptFeb 15, 2024$8.74 (+5.94%)Earnings
- Travere Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 Travere Therapeutics Inc Earnings Call TranscriptNov 07, 2023$7.18 (+8.13%)Earnings
- Travere Therapeutics Inc FILSPARI in IgA Nephropathy Phase 3 PROTECT Study Results Call TranscriptSep 21, 2023
- Q2 2023 Travere Therapeutics Inc Earnings Call TranscriptAug 03, 2023$16.28 (-2.05%)Earnings
- Mirum Pharmaceuticals Inc To Acquire Travere Therapeutics Inc Call TranscriptJul 17, 2023
- Travere Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Travere Therapeutics Inc at William Blair Growth Stock Conference TranscriptJun 06, 2023
- Travere Therapeutics Inc Pegtibatinase in Classical Homocystinuria Phase 1/2 COMPOSE Study Results Call TranscriptMay 31, 2023
- Travere Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Travere Therapeutics Inc Earnings Call TranscriptMay 04, 2023$15.97 (+0.38%)Earnings
- Travere Therapeutics Inc Corporate Update Call TranscriptMay 01, 2023
- Travere Therapeutics Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) TranscriptApr 04, 2023
- Travere Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Travere Therapeutics Inc Earnings Call TranscriptFeb 23, 2023$21.88 (+4.84%)Earnings
- Travere Therapeutics Inc FDA Accelerated Approval of FILSPARI (Sparsentan) Call TranscriptFeb 17, 2023
- Travere Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Travere Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Travere Therapeutics Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Travere Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 Travere Therapeutics Inc Earnings Call TranscriptOct 27, 2022$22.48 (+1.08%)Earnings
- Travere Therapeutics Inc to Discuss the Regulatory Update Call TranscriptOct 13, 2022
- Q2 2022 Travere Therapeutics Inc Earnings Call TranscriptAug 04, 2022$25.79 (+7.46%)Earnings
- Travere Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Travere Therapeutics Inc Earnings Call TranscriptMay 05, 2022$24.59 (-5.09%)Earnings
- Travere Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Q4 2021 Travere Therapeutics Inc Earnings Call TranscriptFeb 24, 2022$27.16 (+4.10%)Earnings
- Travere Therapeutics Inc to Discuss the Topline Results from the Ongoing Phase 1/2 COMPOSE Study of Pegtibatinase in Classical Homocystinuria Call TranscriptDec 15, 2021
- Q3 2021 Travere Therapeutics Inc Earnings Call TranscriptOct 28, 2021$26.59 (+1.49%)Earnings
- Travere Therapeutics Inc Topline Interim Results from the Phase 3 PROTECT Study of Sparsentan in IgA Nephropathy Corporate Call TranscriptAug 16, 2021
- Q2 2021 Travere Therapeutics Inc Earnings Call TranscriptJul 29, 2021$13.84 (-1.77%)Earnings
- Travere Therapeutics Inc to Discuss Regulatory Update on Sparsentan Development Program for Focal Segmental Glomerulosclerosis Call TranscriptMay 25, 2021
- Travere Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 Travere Therapeutics Inc Earnings Call TranscriptMay 06, 2021$23.5 (-2.08%)Earnings
- Travere Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Q4 2020 Travere Therapeutics Inc Earnings Call TranscriptMar 01, 2021$30.56 (-0.84%)Earnings
- Travere Therapeutics, Inc. - Special Call TranscriptFeb 02, 2021
- Travere Therapeutics Inc Corporate Analyst Meeting TranscriptDec 09, 2020
- Q3 2020 Retrophin Inc Earnings Call TranscriptNov 05, 2020$20.88 (-1.69%)Earnings
- Retrophin Inc Announces Agreement to Acquire Orphan Technologies Conference Call TranscriptOct 22, 2020
- Q2 2020 Retrophin Inc Earnings Call TranscriptJul 30, 2020$20.69 (+2.43%)Earnings
- Q1 2020 Retrophin Inc Earnings Call TranscriptMay 11, 2020$16.55 (+8.17%)Earnings
- Retrophin Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Q4 2019 Retrophin Inc Earnings Call TranscriptFeb 24, 2020$16.56 (-4.17%)Earnings
- Q3 2019 Retrophin Inc Earnings Call TranscriptOct 30, 2019$12 (+4.44%)Earnings
- Retrophin, Inc. - Special Call TranscriptAug 22, 2019
- Q2 2019 Retrophin Inc Earnings Call TranscriptAug 06, 2019$19.24 (+1.96%)Earnings
- Q1 2019 Retrophin Inc Earnings Call TranscriptMay 07, 2019$18.86 (-3.18%)Earnings
- Retrophin Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2019
- Q4 2018 Retrophin Inc Earnings Call TranscriptFeb 26, 2019$21.34 (-0.14%)Earnings
Q1 2022 Travere Therapeutics Inc Earnings Call Transcript
Good day, and welcome to the Travere Therapeutics Conference Call. Today's conference is being recorded.
At this time, I'd like to turn the conference over to the Senior Vice President of Investor Relations, Chris Cline. Please go ahead, sir.
Great. Thank you, Justin. Good afternoon, and welcome to Travere Therapeutics First Quarter 2022 Financial Results and Corporate Update Call. Thank you all for joining us. Today's call will be led by our Chief Executive Officer, Dr. Eric Dube. Eric will be joined for the prepared remarks by Dr. Jula Inrig, our Chief Medical Officer; Peter Heerma, our Chief Commercial Officer; and our Chief Financial Officer, Laura Clague. Dr. Bill Rote, Senior Vice President of Research and Development, will join us for the Q&A session.
Before we begin, I would like to remind everyone that statements made during this call regarding matters that are not historical facts are forward-looking statements within the safe harbor provisions of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)